Prashant Chaudhari

Logical synthetic strategies and structure-activity relationship of indolin-2-one hybrids as small molecule anticancer agents: An overview

Prashant Chaudhari, Sanjay J. Surana, Atul A. Shirkhedkar et al. · Journal of Molecular Structure · 2021 · 33 citations

Combinatorial Chemistry, Medicinal Chemistry, Bioorganic Chemistry +11

In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening

Prashant Chaudhari, Sanjay B. Bari · Molecular Diversity · 2015 · 28 citations

Medicinal Chemistry, Virtual Screening, Drug Target +11

Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones <i>via In Silico</i> Design Followed by Supramolecular Green Synthesis

Prashant Chaudhari, Sanjay B. Bari, Sanjay J. Surana et al. · ACS Omega · 2022 · 26 citations · Full text

Novel crosslinked nanoparticles of chitosan oligosaccharide and dextran sulfate for ocular administration of dorzolamide against glaucoma

Sagar R. Pardeshi, Mahesh P. More, Chandrakantsing V. Pardeshi et al. · Journal of Drug Delivery Science and Technology · 2023 · 23 citations

Ocular Disease, Ophthalmology, Chitosan Oligosaccharide +9

Medicinal chemistry of non-peptidomimetic dipeptidyl peptidase IV (DPP IV) inhibitors for treatment of Type-2 diabetes mellitus: Insights on recent development

Jaya P. Ambhore, Purushottam R. Laddha, Anjali Nandedkar et al. · Journal of Molecular Structure · 2023 · 21 citations

Medicinal Chemistry, Type-2 Diabetes Mellitus, Pharmaceutical Science +12